Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥2.27T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥1.16T2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥3.98T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.89T2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥956.8bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥118.4bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥50.3bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥153.1bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥66.1bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥122.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥46.9bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥290.4bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥147.2bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥61.9bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥73.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥29.1bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥177.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥85.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥35.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥91.5bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥38.2bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥209.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥101.9bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥42.7bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥6.00Tat 2022-09-30Cons.Assets IFRS
Total assets¥5.57Tat 2022-03-31Cons.Assets IFRS
Total assets¥5.32Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.96Tat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥3.73Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥2.04Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥1.84Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.67Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥1.57Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.63Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.32Tat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥253.7bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥245.8bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥257.7bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥349.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥93.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥346.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥166.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥117.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥128.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥107.5bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥15.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥336.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥151.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥52.022022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥20.442022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥124.682021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥59.942021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥24.82021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥49.792022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥19.582022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥115.032021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥55.132021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥22.822021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio27.1%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.8%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥205.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥108.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥96.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥6.6bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥152.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥152.9bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥6.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue2022-04-01 → 2022-09-30¥771.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue external2022-04-01 → 2022-09-30¥745.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥26.0bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentsegment profit2022-04-01 → 2022-09-30¥22.7bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥212.3bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥212.0bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥309m
jpcrp040300-q2r_E00808-000Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥3.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2022-04-01 → 2022-09-30¥573.7bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2022-04-01 → 2022-09-30¥569.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2022-04-01 → 2022-09-30¥54.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥659.7bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥634.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥25.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥42.3bn
—segment totalrevenue2022-04-01 → 2022-09-30¥2.22T
—segment totalrevenue external2022-04-01 → 2022-09-30¥2.16T
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥56.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥122.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥2.42T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥2.27T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥152.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥129.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥172.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥81.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥90.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥6.1bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥140.6bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥140.6bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥7.3bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue2021-04-01 → 2021-09-30¥614.8bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue external2021-04-01 → 2021-09-30¥593.9bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥20.9bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentsegment profit2021-04-01 → 2021-09-30¥62.2bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue2021-04-01 → 2021-09-30¥198.7bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue external2021-04-01 → 2021-09-30¥198.5bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥171m
jpcrp040300-q2r_E00808-000Health Carereportable segmentsegment profit2021-04-01 → 2021-09-30¥1.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2021-04-01 → 2021-09-30¥447.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2021-04-01 → 2021-09-30¥444.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2021-04-01 → 2021-09-30¥48.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥592.2bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥566.7bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥25.5bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥45.8bn
—segment totalrevenue2021-04-01 → 2021-09-30¥1.85T
—segment totalrevenue external2021-04-01 → 2021-09-30¥1.80T
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥49.8bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥157.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥2.03T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.89T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥140.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥163.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 950
ItemContextValueUnit
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row2Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row2Member2400
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row2Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row3Member2800
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row3Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row3Member2800
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row3Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row4Member169900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row4Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row4Member169900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row4Member0.0001
Number of shares held in own name treasury shares etcCurrentQuarterInstant82055200
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant82055200
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0545
Number of male directors and other officersFilingDateInstant16
Number of female directors and other officersFilingDateInstant3
Ratio of female directors and other officersFilingDateInstant0.158
Revenue IFRSPrior1YTDDuration1885095000000JPY
Revenue IFRSCurrentYTDDuration2269808000000JPY
Cost of sales IFRSPrior1YTDDuration1326160000000JPY
Cost of sales IFRSCurrentYTDDuration1696653000000JPY
Gross profit IFRSPrior1YTDDuration558935000000JPY
Gross profit IFRSCurrentYTDDuration573155000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration410690000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration455142000000JPY
Other operating income IFRSPrior1YTDDuration8528000000JPY
Other operating income IFRSCurrentYTDDuration8379000000JPY
Other operating expenses IFRSPrior1YTDDuration13279000000JPY
Other operating expenses IFRSCurrentYTDDuration15247000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration9643000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration7207000000JPY
Operating profit loss IFRSPrior1YTDDuration153137000000JPY
Operating profit loss IFRSCurrentYTDDuration118352000000JPY
Finance income IFRSPrior1YTDDuration5418000000JPY
Finance income IFRSCurrentYTDDuration16538000000JPY
Finance costs IFRSPrior1YTDDuration11390000000JPY
Finance costs IFRSCurrentYTDDuration12923000000JPY
Profit loss before tax IFRSPrior1YTDDuration147165000000JPY
Profit loss before tax IFRSCurrentYTDDuration121967000000JPY
Income tax expense IFRSPrior1YTDDuration45230000000JPY
Income tax expense IFRSCurrentYTDDuration30439000000JPY
Profit loss IFRSPrior1YTDDuration101935000000JPY
Profit loss IFRSCurrentYTDDuration91528000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration85166000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration73944000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration16769000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration17584000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration59.94
Basic earnings loss per share IFRSCurrentYTDDuration52.02

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass